Electrophysiology Diagnostic Catheters - Medical Devices Pipeline Assessment, 2018
June 2018
65
About the Report
About the Report
Electrophysiology Diagnostic Catheters-Medical Devices Pipeline Assessment, 2018
Summary
GlobalData's Medical Devices sector report, Electrophysiology Diagnostic Catheters-Medical Devices Pipeline Assessment, 2018" provides an overview of Electrophysiology Diagnostic Catheters currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Electrophysiology Diagnostic Catheters pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Electrophysiology Diagnostic Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Electrophysiology Diagnostic Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to-
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Electrophysiology Diagnostic Catheters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Products
Products
Aust Development, LLC, Endovascular Cardiac Optical Mapping Device; Boston Scientific Corp, Lesion Assessment Device; CathRx Ltd, Khelix Fixed Catheter; CathRx Ltd, Khelix Fixed Loop EP Catheter; CathRx Ltd, Khelix Fixed Loop Steerable EP Catheter; CathRx Ltd, Khelix Steerable Catheter; CathRx Ltd, Khelix Variable Loop Steerable EP Catheter; Cordis Corp, EP Lesion Assessment Device; Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon, Fibrillation Catheter; King's College London, Steerable Catheter; Medtronic plc, Second Generation Achieve Advance Mapping Catheter; MicroPort Scientific Corp, Circular Diagnostic Catheter; MicroPort Scientific Corp, Variable Loop; University of Maryland, Steerable Actuated Catheter
Companies
Aust Development, LLC
Boston Scientific Corp
CathRx Ltd
Cordis Corp
Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon
King's College London
Medtronic plc
MicroPort Scientific Corp
University of Maryland
Table of Contents
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 6
2.1 Electrophysiology Diagnostic Catheters Overview 6
3 Products under Development 7
3.1 Electrophysiology Diagnostic Catheters-Pipeline Products by Stage of Development 7
3.2 Electrophysiology Diagnostic Catheters-Pipeline Products by Segment 8
3.3 Electrophysiology Diagnostic Catheters-Pipeline Products by Territory 9
3.4 Electrophysiology Diagnostic Catheters-Pipeline Products by Regulatory Path 10
3.5 Electrophysiology Diagnostic Catheters-Pipeline Products by Estimated Approval Date 11
4 Electrophysiology Diagnostic Catheters-Pipeline Products under Development by Companies 12
4.1 Electrophysiology Diagnostic Catheters Companies-Pipeline Products by Stage of Development 12
4.2 Electrophysiology Diagnostic Catheters-Pipeline Products by Stage of Development 13
5 Electrophysiology Diagnostic Catheters Companies and Product Overview 14
5.1 Aust Development, LLC Company Overview 14
5.1.1 Aust Development, LLC Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Boston Scientific Corp Company Overview 15
5.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 CathRx Ltd Company Overview 16
5.3.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 16
5.4 Cordis Corp Company Overview 20
5.4.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 20
5.5 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview 21
5.5.1 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview 21
5.6 King's College London Company Overview 22
5.6.1 King's College London Pipeline Products & Ongoing Clinical Trials Overview 22
5.7 Medtronic plc Company Overview 23
5.7.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 23
5.8 MicroPort Scientific Corp Company Overview 24
5.8.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 24
5.9 University of Maryland Company Overview 26
5.9.1 University of Maryland Pipeline Products & Ongoing Clinical Trials Overview 26
6 Electrophysiology Diagnostic Catheters- Recent Developments 27
6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 27
6.2 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC 29
6.3 May 07, 2018: PlaqueTec Data Presented at EAS Show Lack of Correlation between Localised Coronary Artery Inflammatory Biomarker Expression and Systemic Elevation of Biomarkers including hsCRP 29
6.4 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 30
6.5 May 03, 2018: Nation's First Cardiac Ablation with Mapping System Recently Cleared by the FDA Performed at Penn Medicine 31
6.6 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018 32
6.7 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 34
6.8 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 35
6.9 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results 37
6.10 Feb 08, 2018: MicroPort Signs Strategic Agreement with Neptunus Biotechnology 37
6.11 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 38
6.12 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 40
6.13 Jan 09, 2018: MicroPort Selected as "2017 China Innovative Medical Device Company" 40
6.14 Jan 09, 2018: MicroPort Awarded 2017 Shanghai Pilot Enterprise with Outstanding Innovation 41
6.15 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 41
6.16 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 42
6.17 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 43
6.18 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 46
6.19 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 47
6.20 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 47
6.21 Oct 25, 2017: Bard Announces Third Quarter Results 49
6.22 Oct 24, 2017: Acutus Medical Received FDA Clearance For AcQMap 3D Imaging and Mapping Catheter for Complex Arrhythmias 50
6.23 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 51
6.24 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 52
6.25 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY 53
6.26 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 54
6.27 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 57
6.28 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 57
6.29 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 59
6.30 Jul 07, 2017: MPSC New COO Glendy Wang on Board 59
6.31 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 60
7 Appendix 62
7.1 Methodology 62
7.2 About GlobalData 65
7.3 Contact Us 65
7.4 Disclaimer 65
List of Figure
1.2 List of Figures
Figure 1: Electrophysiology Diagnostic Catheters-Pipeline Products by Stage of Development 7
Figure 2: Electrophysiology Diagnostic Catheters-Pipeline Products by Segment 8
Figure 3: Electrophysiology Diagnostic Catheters-Pipeline Products by Territory 9
Figure 4: Electrophysiology Diagnostic Catheters-Pipeline Products by Regulatory Path 10
Figure 5: Electrophysiology Diagnostic Catheters-Pipeline Products by Estimated Approval Date 11
List of Table
1.1 List of Tables
Table 1: Electrophysiology Diagnostic Catheters-Pipeline Products by Stage of Development 7
Table 2: Electrophysiology Diagnostic Catheters-Pipeline Products by Segment 8
Table 3: Electrophysiology Diagnostic Catheters-Pipeline Products by Territory 9
Table 4: Electrophysiology Diagnostic Catheters-Pipeline Products by Regulatory Path 10
Table 5: Electrophysiology Diagnostic Catheters-Pipeline Products by Estimated Approval Date 11
Table 6: Electrophysiology Diagnostic Catheters Companies-Pipeline Products by Stage of Development 12
Table 7: Electrophysiology Diagnostic Catheters-Pipeline Products by Stage of Development 13
Table 8: Aust Development, LLC Pipeline Products & Ongoing Clinical Trials Overview 14
Table 9: Endovascular Cardiac Optical Mapping Device-Product Status 14
Table 10: Endovascular Cardiac Optical Mapping Device-Product Description 14
Table 11: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 15
Table 12: Lesion Assessment Device-Product Status 15
Table 13: Lesion Assessment Device-Product Description 15
Table 14: CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 16
Table 15: Khelix Fixed Catheter-Product Status 16
Table 16: Khelix Fixed Catheter-Product Description 16
Table 17: Khelix Fixed Loop EP Catheter-Product Status 17
Table 18: Khelix Fixed Loop EP Catheter-Product Description 17
Table 19: Khelix Fixed Loop Steerable EP Catheter-Product Status 17
Table 20: Khelix Fixed Loop Steerable EP Catheter-Product Description 18
Table 21: Khelix Steerable Catheter-Product Status 18
Table 22: Khelix Steerable Catheter-Product Description 18
Table 23: Khelix Variable Loop Steerable EP Catheter-Product Status 19
Table 24: Khelix Variable Loop Steerable EP Catheter-Product Description 19
Table 25: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 20
Table 26: EP Lesion Assessment Device-Product Status 20
Table 27: EP Lesion Assessment Device-Product Description 20
Table 28: Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview 21
Table 29: Fibrillation Catheter-Product Status 21
Table 30: Fibrillation Catheter-Product Description 21
Table 31: King's College London Pipeline Products & Ongoing Clinical Trials Overview 22
Table 32: Steerable Catheter-Product Status 22
Table 33: Steerable Catheter-Product Description 22
Table 34: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 23
Table 35: Second Generation Achieve Advance Mapping Catheter-Product Status 23
Table 36: Second Generation Achieve Advance Mapping Catheter-Product Description 23
Table 37: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 24
Table 38: Circular Diagnostic Catheter-Product Status 24
Table 39: Circular Diagnostic Catheter-Product Description 24
Table 40: Variable Loop-Product Status 25
Table 41: Variable Loop-Product Description 25
Table 42: University of Maryland Pipeline Products & Ongoing Clinical Trials Overview 26
Table 43: Steerable Actuated Catheter-Product Status 26
Table 44: Steerable Actuated Catheter-Product Description 26
Table 45: Glossary 64
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.